IDYA
Price
$19.15
Change
-$0.48 (-2.45%)
Updated
May 21 closing price
Capitalization
1.68B
82 days until earnings call
SLN
Price
$5.14
Change
-$0.00 (-0.00%)
Updated
May 21 closing price
Capitalization
137.44M
Interact to see
Advertisement

IDYA vs SLN

Header iconIDYA vs SLN Comparison
Open Charts IDYA vs SLNBanner chart's image
IDEAYA Biosciences
Price$19.15
Change-$0.48 (-2.45%)
Volume$1.6M
Capitalization1.68B
Silence Therapeutics
Price$5.14
Change-$0.00 (-0.00%)
Volume$168.72K
Capitalization137.44M
IDYA vs SLN Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. SLN commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and SLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (IDYA: $19.15 vs. SLN: $5.14)
Brand notoriety: IDYA and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 101% vs. SLN: 66%
Market capitalization -- IDYA: $1.68B vs. SLN: $137.44M
IDYA [@Biotechnology] is valued at $1.68B. SLN’s [@Biotechnology] market capitalization is $137.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLN is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 7 TA indicator(s) are bullish while SLN’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 7 bullish, 3 bearish.
  • SLN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IDYA is a better buy in the short-term than SLN.

Price Growth

IDYA (@Biotechnology) experienced а +11.99% price change this week, while SLN (@Biotechnology) price change was +26.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was -1.65%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

SLN is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.68B) has a higher market cap than SLN($137M). SLN (-25.291) and IDYA (-25.486) have similar YTD gains . SLN has higher annual earnings (EBITDA): -71.65M vs. IDYA (-356.46M). IDYA has more cash in the bank: 693M vs. SLN (137M). SLN has less debt than IDYA: SLN (60K) vs IDYA (26M). SLN has higher revenues than IDYA: SLN (27.7M) vs IDYA (7M).
IDYASLNIDYA / SLN
Capitalization1.68B137M1,224%
EBITDA-356.46M-71.65M498%
Gain YTD-25.486-25.291101%
P/E RatioN/AN/A-
Revenue7M27.7M25%
Total Cash693M137M506%
Total Debt26M60K43,333%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
65
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYASLN
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 7 days ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
89%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FOPPX57.92N/A
N/A
Franklin Growth Opportunities R6
CAMIX29.50N/A
N/A
Cambiar International Equity Inv
HIBSX102.58N/A
N/A
Hartford Stock HLS IB
AQGRX11.62-0.13
-1.11%
AQR Global Equity R6
JIDVX11.75-0.23
-1.92%
Janus Henderson U.S. Dividend Income I

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-2.45%
IMNM - IDYA
58%
Loosely correlated
-7.48%
RCKT - IDYA
58%
Loosely correlated
-3.80%
NTLA - IDYA
57%
Loosely correlated
-4.86%
CGON - IDYA
57%
Loosely correlated
-1.28%
CRNX - IDYA
56%
Loosely correlated
-4.53%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
N/A
CLLS - SLN
43%
Loosely correlated
-1.30%
CMVLF - SLN
38%
Loosely correlated
N/A
IDYA - SLN
37%
Loosely correlated
-2.45%
NTLA - SLN
37%
Loosely correlated
-4.86%
RCKT - SLN
36%
Loosely correlated
-3.80%
More